Vertex Pharmaceuticals announced Tom Graney appointment for the Senior Vice President and Chief Financial Officer (CFO). Mr. Graney will begin his new role with Vertex on September 12, 2017 and will be reporting to the Executive Vice President and COO Ian Smith. Previously Mr. Graney served as a CFO and Senior Vice President of Finance and Corporate Strategy at Ironwood Pharmaceuticals.
Mr. Graney will be responsible for the development and execution of the financial strategy and operations that will support the Vertex’s business plans that include the Finance, Accounting and Internal Audit functions.
Ian Smith, Executive Vice President and Chief Operating Officer of Vertex said, “As Vertex continues its evolution to a leading global biotech, it is critical that we continue to build a strong and experienced leadership team. Tom has the ideal blend of financial acumen, leadership skills, and industry experience that will be important as Vertex grows and expands as a global company.”
Tom Graney said, “I am thrilled to take on this important role with Vertex, a company that I have long admired for its unwavering commitment to patients and to discovering, developing and commercializing transformative medicines for people with serious and life-threatening diseases.”